![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Gremse David A
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.2, Iss.10, 2001-10, pp. : 1663-1670
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Pharmacokinetics and Pharmacodynamics of Etravirine
Clinical Pharmacokinetics, Vol. 48, Iss. 9, 2009-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Pharmacokinetics and Pharmacodynamics of Vildagliptin
By He Yan-Ling
Clinical Pharmacokinetics, Vol. 51, Iss. 3, 2012-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Pharmacokinetics and Pharmacodynamics of Bromfenac
By Skjodt N.M.
Clinical Pharmacokinetics, Vol. 36, Iss. 6, 1999-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Pharmacokinetics and Pharmacodynamics of Aliskiren
Clinical Pharmacokinetics, Vol. 47, Iss. 8, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Pharmacokinetics and Pharmacodynamics of Isepamicin
By Tod M. Padoin C. Petitjean O.
Clinical Pharmacokinetics, Vol. 38, Iss. 3, 2000-03 ,pp. :